District Court Dismisses Novartis Speaker Program Suit

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

District Court Dismisses Novartis Speaker Program Suit

J.W. Schomisch

September 18, 2022 at 01:40 PM EST

A whistleblower lawsuit alleging a nationwide kickback scheme involving a Novartis speakers’ program was dismissed Sept. 13 in the U.S. District Court for the Southern District of New York. In the case, realtor Steven Camburn alleged that Novartis sales representatives organized speaker programs for Gilenya, a drug approved to treat multiple sclerosis in September 2010, which... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

District Court Dismisses Novartis Speaker Program Suit

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT